DMTK - DermTech, Inc.

QQQ $ 448.32 $ -0.63 (-0.14 %)

DIA $ 397.49 $ -0.39 (-0.1 %)

SPY $ 526.25 $ 0.32 (0.06 %)

TLT $ 91.88 $ 0.04 (0.04 %)

GLD $ 219.18 $ 0.05 (0.02 %)

Previous Close

$ 0.638

Open

$ 0.62

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.62 - $ 0.62

52 Week Range

$ 0.57 - $ 3.90

Volume

145,765

Average Volume

Market Cap

20.83M

Beta (5Y Monthly)

$ 2.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-04-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-05-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	05-13-2020	03-31-2020	10-Q
18	03-11-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	06-14-2019	03-31-2019	10-K
22	02-14-2019	12-31-2018	10-Q
23	11-14-2018	09-30-2018	10-Q
24	08-10-2018	06-30-2018	10-Q
25	06-29-2018	03-31-2018	10-K
26	02-13-2018	12-31-2017	10-Q
27	11-13-2017	09-30-2017	10-Q
28	08-14-2017	06-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

DermTech Q1 2024 Adj EPS $(0.58) Misses $(...
05/14/2024 20:30:48

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.57) by...

What Analysts Are Saying About DermTech Stock
04/19/2024 17:01:31

Lake Street Downgrades DermTech to Hold, A...
04/19/2024 16:01:45

Lake Street analyst Thomas Flaten downgrades DermTech (NASDAQ:DMTK) from Buy to Hold and announces $0.63 price target.

Stephens & Co. Reiterates Equal-Weight on ...
04/19/2024 14:36:50

Stephens & Co. analyst Mason Carrico reiterates DermTech (NASDAQ:DMTK) with a Equal-Weight and maintains $1.5 price target.

BTIG Downgrades DermTech to Neutral
04/19/2024 10:35:22

BTIG analyst Sung Ji Nam downgrades DermTech (NASDAQ:DMTK) from Buy to Neutral.

DermTech Intends To Continue Laboratory Op...
04/18/2024 20:20:08

The Company anticipates incurring a one-time restructuring charge of approximately $1.6 million in the second quarter of 2024 i...

DermTech To Seek Strategic Alternatives; P...
04/18/2024 20:18:56

Potential strategic alternatives that may be explored or evaluated include an acquisition, merger, reverse merger, business com...

DermTech Presents Research Abstracts At 20...
03/08/2024 13:06:46

BTIG Maintains Buy on DermTech, Lowers Pri...
03/07/2024 16:42:54

BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $4 to $2.

Stephens & Co. Maintains Equal-Weight on D...
03/05/2024 14:11:58

Stephens & Co. analyst Mason Carrico maintains DermTech (NASDAQ:DMTK) with a Equal-Weight and lowers the price target fr...

Why Zscaler Shares Are Trading Lower By 10...
03/01/2024 18:19:25

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/01/2024 17:34:56

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/01/2024 13:09:49

Recap: DermTech Q4 Earnings
02/29/2024 21:05:18

DermTech Q4 2023 GAAP EPS $(0.560) Beats $...
02/29/2024 21:02:15

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.560) per share which beat the analyst consensus estimate of $(0.570) by...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

DermTech Announces Restructuring Actions A...
01/31/2024 21:41:52

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/31/2024 13:05:57

DermTech Announces Topline Results From St...
01/18/2024 13:06:45

DermTech Discontinus Optional TERT Add-On ...
01/16/2024 13:30:13

- Trust 2 Study confirms negative predictive value (NPV) of 99.7% for the foundational gene expression assay- Optional TERT pro...